Editing Adjuvant and Salvage Radiotherapy After Prostatectomy (2019) (section)

== Future trials ==

* '''RTOG 0534'''
** Objective: compare prostate bed +/- ADT +/- pelvic lymph node RT
** Population: post-prostatectomy patients (pT2N0/Nx or pT3N0/Nx) with Gleason scores ≤9, with or without positive margins, and with post-RP PSA of ≥ 0.1 ng/mL to < 2.0 ng/mL
** Randomized to to prostate bed RT, prostate bed RT plus short-term ADT (four to six months) or pelvic lymph node RT plus prostate bed RT plus short-term ADT.
* '''RADICALS'''
** Addressing two critical questions in post-RP patients:
*** Comparative efficacy of the ART vs. SRT approach
*** Concurrent randomization addresses the question of the role of hormone therapy